These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10931838)

  • 1. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
    Draganov DI; Stetson PL; Watson CE; Billecke SS; La Du BN
    J Biol Chem; 2000 Oct; 275(43):33435-42. PubMed ID: 10931838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.
    Draganov DI; Teiber JF; Speelman A; Osawa Y; Sunahara R; La Du BN
    J Lipid Res; 2005 Jun; 46(6):1239-47. PubMed ID: 15772423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
    Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
    Ng CJ; Wadleigh DJ; Gangopadhyay A; Hama S; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    J Biol Chem; 2001 Nov; 276(48):44444-9. PubMed ID: 11579088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3.
    Teiber JF; Draganov DI; La Du BN
    Biochem Pharmacol; 2003 Sep; 66(6):887-96. PubMed ID: 12963475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R.
    Watson CE; Draganov DI; Billecke SS; Bisgaier CL; La Du BN
    Pharmacogenetics; 2001 Mar; 11(2):123-34. PubMed ID: 11266077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
    Liu Y; Mackness B; Mackness M
    Free Radic Biol Med; 2008 Sep; 45(6):743-8. PubMed ID: 18585453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase genes and disease.
    Hegele RA
    Ann Med; 1999 Jun; 31(3):217-24. PubMed ID: 10442677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of serum paraoxonase PON3 by family shuffling and ancestor/consensus mutagenesis, and its biochemical characterization.
    Khersonsky O; Rosenblat M; Toker L; Yacobson S; Hugenmatter A; Silman I; Sussman JL; Aviram M; Tawfik DS
    Biochemistry; 2009 Jul; 48(28):6644-54. PubMed ID: 19492856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy.
    Campo S; Sardo AM; Campo GM; Avenoso A; Castaldo M; D'Ascola A; Giunta E; Calatroni A; Saitta A
    Mutat Res; 2004 Feb; 546(1-2):75-80. PubMed ID: 14757195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
    Teiber JF; Xiao J; Kramer GL; Ogawa S; Ebner C; Wolleb H; Carreira EM; Shih DM; Haley RW
    Biochem Biophys Res Commun; 2018 Oct; 505(1):87-92. PubMed ID: 30241945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three-gene paraoxonase family: physiologic roles, actions and regulation.
    Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E
    Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.